NFE2L2 and esophageal squamous cell carcinoma: Exome sequencing reveals prevalent TP53 mutations in ESCC, alongside rare mutations in NOTCH1, NFE2L2, and CDKN2A5 suggesting transcriptome remodeling as a risk factor in ESCC development.